1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"TNBC Foundation–AACR NextGen Grant for Transformative Cancer Research 2026" is currently closed and not accepting applications.
TNBC Foundation–AACR NextGen Grant for Transformative Cancer Research 2026 is sponsored by Triple Negative Breast Cancer Foundation and American Association for Cancer Research. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Triple Negative Breast Cancer NextGen Grants | AACR Grants Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
Patient / Caregivers / Public Researchers / Professionals Information for Current Grantees Research Training and Fellowships Career Development Awards Independent Research Grants Triple Negative Breast Cancer Research Foundation-AACR NextGen Grant for Transformative Cancer Research Grant Amount $450,000 USD Start of Grant Term November 1, 2024 Letter of Intent Deadline May 16, 2024 1:00 PM (ET) Letter of Intent Notification Date July 2024 Application Deadline August 13, 2024 1:00 PM (ET) Decision Date October 2024 Additional Information Additional details regarding this grant program can be found in the Program Guidelines and Competitive Letter of Intent Instructions .
Final determinations of eligibility will not be completed until the AACR is in receipt of the submitted Letter of Intent. The Triple Negative Breast Cancer Foundation (TNBCF)-AACR NextGen Grant for Transformative Cancer Research represent the AACR’s flagship funding initiative to stimulate highly innovative research from young investigators.
This grant mechanism is intended to promote and support creative, paradigm shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence.
While the research proposed for funding may be basic, translational, or clinical in nature in any area of cancer research, the 2024 TNBCF-AACR NextGen Grant will be awarded only to triple negative breast cancer-focused projects.
The grants provide $450,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, graduate students (including tuition costs), and research assistants, research/laboratory supplies, equipment, travel applicable to the research project, publication charges for manuscripts that pertain directly to the funded project, other research expenses, and indirect costs.
Please review all Program Guidelines and Competitive Letter of Intent Instructions before submitting an application. Research Project Criteria The proposed research must represent a highly innovative approach to a major contemporary challenge in cancer research.
The funded projects must have the potential to lead to groundbreaking discoveries in the field, and transform our understanding of the tumorigenesis process and/or our ability to treat, detect, or prevent cancer.
While the research proposed for funding may be basic, translational, or clinical in nature in any area of cancer research, the 2024 TNBCF-AACR NextGen Grant for Transformative Cancer Research will be awarded only to triple negative breast cancer-focused projects. Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.
At the start of the grant term on November 1, 2024, applicants must: Hold a tenure-eligible appointment (or equivalent, if institution does not follow a tenure system) at the rank of assistant professor (appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible.
Applicants that have progressed to associate professor appointments are also not eligible) If eligibility is based on a future position, the position must be confirmed at the time of submission, and CANNOT be contingent upon receiving this grant.
If the future position is at a different institution than the applicant’s current institution, the applicant must contact the AACR’s Scientific Review and Grants Administration Department (AACR’s RGA) at [email protected] before submitting their Letter of Intent for information on additional verification materials/signatures that may be required.
Have held a tenure-eligible assistant professor appointment for no more than three years (i.e., cannot have held a tenure-eligible appointment prior to November 1, 2021) Work at an academic, medical, or research institution anywhere in the world Final determinations of eligibility will not be completed until the AACR is in receipt of the submitted Letter of Intent. There are no citizenship or geographic requirements.
However, by submitting a Letter of Intent for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that their visa status will provide sufficient time to complete the project and grant term at the institution from which they applied. AACR Membership Requirements Applicants must be AACR Active members in good standing (dues paid for the current year).
Please be informed that AACR offers reduced membership due rates for applicants from countries with emerging economies based on the World Bank listing. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR membership by the Letter of Intent (LOI) deadline. Nonmembers can apply for membership online .
Please review the Membership Categories for the category that best fits your qualifications. Nonmembers must obtain a statement of support from a nominator who is an Active AACR member in good standing (dues paid for the current year). Nonmembers requiring assistance with finding a nominator may email [email protected] and include your geographical location to receive a list of members in your area to contact for nominations.
For more information check the membership FAQ . Members can renew their membership through myAACR . You will need your logon (email address) and password to access the member portal.
If you require assistance logging in, please submit a help form . Lapsed members must be members in good standing by the LOI deadline and should contact the Membership Department at [email protected] for assistance. The AACR requires applicants to complete an online Letter of Intent submission by 1:00 p.
m. U.S. Eastern Time on Thursday, May 16, 2024, using the ProposalCentral website at https://proposalcentral. com .
Please review all Program Guidelines and Competitive Letter of Intent Instructions before submitting an application. block needs to be placed in the location where the link block will be displayed--> Breast Cancer Research Foundation-AACR NextGen...
According to the current listing, eligibility includes: Early-career researchers at non-profit institutions focused on triple-negative breast cancer; AACR membership required. Confirm the full requirements in the official notice before applying.
The current listing shows $450,000 per award. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was April 14, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
TNBC Foundation–AACR NextGen Grant for Transformative Cancer Research 2026 is funded by Triple Negative Breast Cancer Foundation and American Association for Cancer Research. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleHouse leadership canceled the September 21 and September 28 session weeks on September 3, leaving four legislative days before members leave until after the November 3 midterms. Three separate deadlines — the continuing resolution, the surface transportation extension, and the statutory freeze on OMB's grant-rule rewrite — now expire on the same day, with a lame-duck Congress and a handful of weeks to resolve them. Here is what that means for anyone holding or chasing a federal award.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read article